期刊文献+

MR-1S融合蛋白的表达、纯化与保存及其抗血清的制备

Expression,purification and preservation of myofibrillogenesis regulator 1S recombinant protein and its antiserum preparation
下载PDF
导出
摘要 目的通过人肌纤生成调节因子1(hMR-1S)基因重组表达获得MR-1S-His融合蛋白,纯化后制备抗MR-1S抗血清;同时确定该蛋白保存的稳定体系,为研究MR-1S蛋白理化性质及其功能提供关键的原料。方法利用原核表达载体pET21a(+),构建pET21a-MR-1S重组质粒,转化大肠杆菌BL21(DE3),异丙基硫代半乳糖苷(IPTG)诱导MR-1S-His融合蛋白表达,亲和纯化后Western blot鉴定;进一步用该融合蛋白免疫新西兰兔,制备抗MR-1S的多克隆抗体。同时通过在不同温度条件下,对4种不同的稳定体系中保存后蛋白活性测定进行比较,确定最合适的稳定保存体系及条件。结果构建了重组质粒pET21a-MR-1S,并在BL21中进行可溶性表达,经Western blot鉴定确认;免疫新西兰兔获得了抗MR-1S抗血清;确定了合适的稳定体系及保存条件。结论在非变性条件下实现了可溶性MR-1S融合蛋白的表达和稳定保存,进一步制备的抗MR-1S抗血清为研究MR-1S的性质及功能奠定了基础。 Objective To obtain the myofibrillogenesis regulator 1S(MR-1S)-His recombinant protein through the expression of MR-1S gene and prepare anti-MR-1S antiserum after purification.To identify the stable system to preserve the recombinant protein,and to provid the reference for the investigation of MR-1S protein characteristics and biological function.Methods The recombinant plasmid pET21a-MR-1S was constructed with pronucleus expression vector pET 21a(+) and transferred into Escherichia coli BL21(DE3),and the expression of MR-1S recombinant protein was induced by isopropyl-beta-D-thiogalactopyranoside(IPTG).The MR-1S recombinant protein was purified by affinity chromatography and identified by Western blot.The anti-MR-1S polyclonal antibodies were prepared by the rabbit-immunized technique.With comparison of the protein activities of 4 stable systems under different temperatures,the most suitable stable preservation system and condition were picked out.Results Recombinant plasmid pET21a-MR-1S was established,and the MR-1S-His recombinant protein was expressed solubly in Escherichia coli BL21(DE3) by the identification of Western blot.The anti-MR-1S antisera were obtained by immunization rabbit,and the satabilization system and preservation condition were definited.Conclusions Under undenatured conditions,the soluble MR-1S recombinant protein is expressed and can be preserved stably,and it lays the foundation for MR-1S characteristices and biological function studies.
出处 《检验医学》 CAS 2012年第10期835-839,共5页 Laboratory Medicine
关键词 肌纤维生成调节因子1 分子克隆 抗体 Myofibrillogenesis regulator 1 Molecular cloning Antibody
  • 相关文献

参考文献6

二级参考文献52

  • 1李天伯,胡洋,王以光,夏焕章.mMR-1基因的克隆和在毕赤酵母中分泌表达[J].生物工程学报,2005,21(1):25-29. 被引量:3
  • 2陈长征,段治军,杨新颖,夏其昌,李伯良,王应睐.T7启动子控制下的多功能大肠杆菌表达系统[J].生物化学与生物物理学报,1996,28(5):531-539. 被引量:8
  • 3Hellstrom I, Raycraft J, Hayden2Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J]. Cancer Res, 2003,63 (13) :3695.
  • 4Drapkin R, Von Horsten HH, Lin YT, et al. Human epididymis protein 4 (HE4) is secreted glyeoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J]. Cancer Res,2005,65(6):2162.
  • 5Kirchhoff C, Habben I, Nell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J]. Biol Reprod 1991,45 : 350.
  • 6Clauss A, Lilja H, Lundwall A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein [ J]. Biochem J, 2002,368:233.
  • 7Schummer M, Wallap VN, Bumgamer RE, et al. Comparative hybridization of an array of 21500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas[ J ]. Gene, 1999,238 ( 1 ) : 375.
  • 8Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer [ J ]. Gynecol Oncol 2005,99(2) :267.
  • 9Moore RG, Brown AK, Miller MC, et al.The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[ J]. Gynecol Oncol,2008,108(2) :402.
  • 10李天伯 刘秀华 冯爽 et al.MR-1,a novel gene in human muscle[J].Acta Biochim et Biophysica Sinica,2004,36(6):412-418.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部